Table 3.
Molecular analysis for sodA among sarcoidosis and control specimens
| Patient | Age, Sex, Racea | Biopsy site | Pathologic diagnosis | Presence of granuloma | Tissue storageb | PCR analysisc | sodA region(s) |
| Sarcoid 1 | 31, M, C | Lung | Sarcoidosis | Yes | Frozen | Mtb complex | 4, 5 |
| Sarcoid 2 | 46, F, C | Lymph node | Sarcoidosis | Yes | Frozen | GDM | 4 |
| Sarcoid 3 | 65, M, U | Lymph node | Sarcoidosis | Yes | Frozen | Mtb complex | 2, 4 |
| Sarcoid 4 | 29, F, C | Lymph node | Sarcoidosis | Yes | FFPE | - | - |
| Sarcoid 5 | 36, F, AA | Lung | Sarcoidosis | Yes | Frozen | Mtb complex | 4 |
| Sarcoid 6 | 48, F, AA | Skin | Sarcoidosis | Yes | FFPE | Mtb complex | 3 |
| Sarcoid 7 | 30, M, AA | Skin | Sarcoidosis | Yes | Frozen | Mtb complex | 5 |
| Sarcoid 8 | 33, F, C | Lymph node | Sarcoidosis | Yes | FFPE | Mtb complex | 4 |
| Sarcoid 9 | 50, F, AA | Lymph node | Sarcoidosis | Yes | FFPE | - | - |
| Sarcoid 10 | 50, M, C | Lymph node | Sarcoidosis | Yes | FFPE | Mtb complex | 5 |
| Sarcoid 11 | 41, F, C | Lymph node | Sarcoidosis | Yes | FFPE | - | - |
| Sarcoid 12 | 39, M, C | Lymph node | Sarcoidosis | Yes | FFPE | - | - |
| Sarcoid 13 | 46, M, AA | Lymph node | Sarcoidosis | Yes | FFPE | Mtb complex | 5 |
| Sarcoid 14 | 45, M, C | Skin | Sarcoidosis | Yes | FFPE | Mtb complex | 2 |
| Sarcoid 15 | 34, F, C | Lymph node | Sarcoidosis | Yes | FFPE | GDM | 4 |
| Sarcoid 16 | 28, M, C | Lymph node | Sarcoidosis | Yes | Frozen | - | - |
| Sarcoid 17 | 34, M, C | Lymph node | Sarcoidosis | Yes | FFPE | Mtb complex | 2 |
| Control 1 | 70, F, C | Colon | Normal colon | No | Frozen | - | - |
| Control 2 | 22, F, C | Lymph node | Histoplasmosis | Yes | Frozen | Mtb complex | 4, 5 |
| Control 3 | 60, M, C | Lymph node | Nocardia | Yes | Frozen | - | - |
| Control 4 | 56, F, C | Lymph node | Cholangial carcinoma | No | Frozen | - | - |
| Control 5 | 49, M, C | Lymph node | Nonspecific Interstitial Pneumonia | No | Frozen | - | - |
| Control 6 | 11, F, AA | Skin | Blastomycosis | Yes | FFPE | - | - |
| Control 7 | 51, F, C | Lung | Histoplasmosis | Yes | FFPE | - | - |
| Control 8 | 26, M, C | Lung | Histoplasmosis | Yes | FFPE | - | - |
| Control 9 | 30, M, C | Lung | Blastomycosis | Yes | FFPE | - | - |
| Control 10 | 25, M, C | Skin | Blastomycosis | Yes | FFPE | - | - |
| Control 11 | 26, M, C | Skin | Blastomycosis | Yes | FFPE | - | - |
| Control 12 | 36, M, U | Lung | Hodgkin's lymphoma | No | Frozen | - | - |
| Control 13 | 15, M, U | Lymph node | Hodgkin's lymphoma | No | Frozen | - | - |
| Control 14 | 68, M, C | Lymph node | Sinus histiocytosis | No | Frozen | - | - |
| Control 15 | 47, F, C | Lymph node | Histoplasmosis | Yes | FFPE | - | - |
| Control 16 | 35, F, C | Lung | Cryptococcus | Yes | FFPE | Mtb complex | 4 |
| TB 1 | 30, M, C | Lymph node | Tuberculosis | Yes | FFPE | Mtb complex | 3, 5 |
| TB 2 | 46, M, C | Knee | Tuberculosis | Yes | FFPE | Mtb complex | 2, 4, 5 |
| TB 3 | 36, M, H | Lymph node | Tuberculosis/AIDS | Yes | FFPE | Mtb complex | 1 – 6 |
aC-Caucasian, AA-African American, H-Hispanic, U-Unknown; bFFPE – formalin-fixed, paraffin-embedded cGDM – genetically distinct mycobacteria